Lb Pharmaceuticals (LBRX) Change in Accured Expenses (2024 - 2026)

Lb Pharmaceuticals' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 219.7% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at -$390000.0 (changed N/A YoY), while the FY2025 annual figure was -$910000.0, down 118.14% from the prior year.
• Change in Accured Expenses was $3.5 million for Q1 2026 at Lb Pharmaceuticals, up from $2.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $3.5 million in Q1 2026 to a low of -$2.9 million in Q4 2024.
• Historically, Change in Accured Expenses has averaged -$97500.0 across 3 years, with a median of -$464500.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses surged 167.18% in 2025, then soared 219.7% in 2026.
• A 3-year view of Change in Accured Expenses shows it stood at -$2.9 million in 2024, then jumped by 167.18% to $2.0 million in 2025, then jumped by 76.28% to $3.5 million in 2026.
• The last three Change in Accured Expenses figures came in at $3.5 million (Q1 2026), $2.0 million (Q4 2025), and -$2.9 million (Q1 2025), per Business Quant data.